- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07394673
Ultralydveiledet serratus posterior superior intercostal planblokk for analgesi i artroskopisk skulderoperasjon (SPSIP)
Postoperativ analgesisk effekt av ultralydveiledet blokk av serratus posterior superior interkostalplan ved artroskopisk skulderoperasjon
This study aimed to evaluate the effectiveness of serratus posterior superior intercostal plane (SPSIP) block in managing postoperative pain in patients undergoing arthroscopic shoulder surgery.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Most patients undergoing arthroscopic shoulder surgery report pain in the postoperative period. Pain management remains a significant concern in patient management, as it affects surgical costs, postoperative mobility, length of hospital stay, patient satisfaction, and surgical outcomes. Multimodal analgesia is recommended for the management of postoperative pain. Regional analgesia is an important component of multimodal analgesia.
The serratus posterior superior intercostal plane (SPSIP) block is a novel regional analgesia technique described in 2023. SPSIP has been reported to provide near-complete sensory blockade in the posterior neck, shoulder, and hemithorax regions.
The main objective of this study is to investigate the effectiveness of SPSIP block in patients undergoing arthroscopic shoulder surgery.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Mursel Ekinci, Assoc prof, MD
- Telefonnummer: +905067137596
- E-post: drmurselekinci@gmail.com
Studer Kontakt Backup
- Navn: Merih Yıldız Eglen, MD
- Telefonnummer: +905059340629
- E-post: Meriheg@yahoo.com
Studiesteder
-
-
Bursa
-
Bursa, Bursa, Tyrkia (Türkiye), 16110
- Rekruttering
- Bursa City Hospital
-
Ta kontakt med:
- Merih Yildiz Eglen, MD
- Telefonnummer: +905059340629
- E-post: meriheg@yahoo.com
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Classified as American Society of Anesthesiologists (ASA) physical status I-II-III
- Scheduled for elective shoulder arthroscopy surgery
- Surgery performed under general anesthesia
- Provision of written informed consent
Exclusion Criteria:
- Use of anticoagulant or antiplatelet medications
- Presence of bleeding diathesis or coagulation disorders
- Known allergy or hypersensitivity to local anesthetics or opioid medications
- Infection or history of previous surgery at the planned block site
- Alcohol or drug dependence
- Cognitive impairment preventing reliable pain assessment using the NRS
- Pregnancy or lactation
- Diabetes mellitus
- Renal or hepatic impairment
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Group SPSIP
Group SPSIP Participants in this arm will receive an ultrasound-guided serratus posterior plane block . |
Serratus Posterior Superior İntercostal Plane (SPSIP) Block will be performed before the surgery in seated position, under standard sterilization conditions.A linear ultrasound probe will be placed in the sagittal plane along the medial border of the scapula, and the second and third ribs, relevant muscles, and the pleura will be identified. The needle will be advanced into the interfascial plane between the serratus posterior superior and intercostal muscles. After confirmation with salin injection , the block will be performed by injecting 30 mL of 0.25% bupivacaine, and the cranio-caudal spread will be visualized under ultrasound. |
|
Ingen inngripen: Group Control
No block procedures will be performed on patients in this arm |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Postoperative 48-Hour PCA Opioid Consumption
Tidsramme: Postoperative 0-8, 8-16, 16-24, 24-48 intervals
|
Total amount of opioid delivered by the patient-controlled analgesia (PCA) device during the first 48 hours after surgery, recorded in milligrams(mg) |
Postoperative 0-8, 8-16, 16-24, 24-48 intervals
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
QoR-15 Recovery Score
Tidsramme: Postoperative 24th and 48th hours
|
The investigators will use the Turkish version of Quality of Recovery (QoR) / QoR-15 questionairre PART A How have you been feeling in the last 24 hours? (0 to 10, where: 0 = none of the time [poor] and 10 = all of the time [excellent]) Able to breathe easily Been able to enjoy food Feeling rested Have had a good sleep Able to look after personal toilet and hygiene unaided Able to communicate with Getting support from hospital doctors and nurses Able to return to work or usual home activities Feeling comfortable and in control Having a feeling of general well-being PART B Have you had any of the following in the last 24 hours? (10 to 0, where: 10 = none of the time [excellent] and 0 = all of the time [poor]) Moderate pain Severe pain Nausea or vomiting Feeling worried or anxious Feeling sad or depressed |
Postoperative 24th and 48th hours
|
|
Dynamic and static NRS scores
Tidsramme: 0, 2, 4, 8, 16, 24, and 48 hours postoperatively
|
Numeric Rating Scale (NRS) (0-10 0: No pain 10: most pain felt) pain scores at rest or movement at predefined postoperative hours |
0, 2, 4, 8, 16, 24, and 48 hours postoperatively
|
|
Total rescue analgesic dose
Tidsramme: Postoperative 24th and 48th hours
|
Despite the use of patient-controlled analgesia (PCA), if the Numeric Rating Scale (NRS) score is ≥4 at any time point, 0.5 mg/kg intravenous meperidine will be administered as |
Postoperative 24th and 48th hours
|
|
Time of first request for rescue analgesia,
Tidsramme: Postoperative 48-Hours
|
Despite the use of patient-controlled analgesia (PCA), if the Numeric Rating Scale (NRS) score is ≥4 at any time point, 0.5 mg/kg intravenous meperidine will be administered. The time will be recorded. |
Postoperative 48-Hours
|
|
Length of Hospital Stay
Tidsramme: the day of surgery, the day of discharge from the hospital
|
Number of days spent in hospital after surgery |
the day of surgery, the day of discharge from the hospital
|
|
Block and Opioid-Related Adverse Effects and Complications
Tidsramme: Postoperative 48-Hours
|
Block- and opioid-related adverse effects and complications, including but not limited to local anesthetic toxicity, hematoma, infection, nerve injury, nausea, vomiting, pruritus, sedation, and respiratory depression, will be recorded |
Postoperative 48-Hours
|
|
Perioperative Remifentanil infusion dose
Tidsramme: Start time: Start of anesthesia administration End time: Termination of anesthesia administration
|
The amount of remifentanil administered in micrograms during general anesthesia |
Start time: Start of anesthesia administration End time: Termination of anesthesia administration
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Merih Yıldız Eglen, MD, Bursa City Hospital
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Tulgar S, Ciftci B, Ahiskalioglu A, Bilal B, Sakul BU, Korkmaz AO, Bozkurt NN, De Cassai A, Torres AJ, Elsharkawy H, Alici HA. Serratus Posterior Superior Intercostal Plane Block: A Technical Report on the Description of a Novel Periparavertebral Block for Thoracic Pain. Cureus. 2023 Feb 3;15(2):e34582. doi: 10.7759/cureus.34582. eCollection 2023 Feb.
- Avci O, Gundogdu O, Balci F, Tekcan MN, Ozbey M. Efficacy of serratus posterior superior intercostal plane block (SPSIPB) on post-operative pain and total analgesic consumption in patients undergoing video-assisted thoracoscopic surgery (VATS): A double-blinded randomised controlled trial. Indian J Anaesth. 2023 Dec;67(12):1116-1122. doi: 10.4103/ija.ija_589_23. Epub 2023 Dec 13.
- Kulturoglu G, Altinsoy S, Ozguner Y, Cataroglu CK. Novel Serratus Posterior Superior Intercostal Plane Block Provided Satisfactory Analgesia after Breast Cancer Surgery: Two Case Reports. Turk J Anaesthesiol Reanim. 2024 Feb 28;52(1):33-35. doi: 10.4274/TJAR.2024.231431.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- BursaCityHOS 4
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .